Literature DB >> 10859047

Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers.

Y Herouy, M O Hellstern, W Vanscheidt, E Schöpf, J Norgauer.   

Abstract

Densitometric analysis shows an accelerated healing rate and a significantly diminished lesional fibrinolytic activity in patients with venous leg ulcers treated topically with the fibrin-stabilising factor XIII compared with controls.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10859047     DOI： 10.1016/S0140-6736(00)02333-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  8 in total

1.  Effect of early administration of coagulation factor XIII on fistula after pancreatic surgery: the FIPS randomized controlled trial.

Authors:  Yoshinori Takeda; Yoshihiro Mise; Naoki Ishizuka; Sohei Harada; Brian Hayama; Yosuke Inoue; Takeaki Ishizawa; Hiromichi Ito; Yu Takahashi; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2018-11-30       Impact factor: 3.445

2.  Soluble CD40 ligand in prediction of acute severe pancreatitis.

Authors:  Jean Louis Frossard; Philippe Morel; Brenda Kwak; Catherine Pastor; Thierry Berney; Léo Buhler; Alain Von Laufen; Sandrine Demulder; François Mach
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 3.  [Chronic wounds. Novel approaches in research and therapy].

Authors:  S A Eming; J Kaufmann; R Löhrer; T Krieg
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

4.  Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.

Authors:  Donato Gemmati; Federica Federici; Gianluca Campo; Silvia Tognazzo; Maria L Serino; Monica De Mattei; Marco Valgimigli; Patrizia Malagutti; Gabriele Guardigli; Paolo Ferraresi; Francesco Bernardi; Roberto Ferrari; Gian L Scapoli; Linda Catozzi
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

5.  Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer.

Authors:  Suguru Shirai; Yoshikane Yamauchi; Fumi Yokote; Takashi Sakai; Yuichi Saito; Yukinori Sakao; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 6.  Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials.

Authors:  Karin Meissner; Hans Distel; Ulla Mitzdorf
Journal:  BMC Med       Date:  2007-03-19       Impact factor: 8.775

Review 7.  Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.

Authors:  Lilla Paragh; Daniel Törőcsik
Journal:  Biomed Res Int       Date:  2017-08-15       Impact factor: 3.411

Review 8.  The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.

Authors:  Christian Kleber; Armin Sablotzki; Sebastian Casu; Martin Olivieri; Kai-Martin Thoms; Johannes Horter; Felix C F Schmitt; Ingvild Birschmann; Dietmar Fries; Marc Maegele; Herbert Schöchl; Michaela Wilhelmi
Journal:  Crit Care       Date:  2022-03-24       Impact factor: 19.334
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.